Sawai Pharmaceutical Co., Ltd. Stock Japan Exchange
Equities
4555
JP3323050009
Pharmaceuticals
Sales 2024 | 177B 1.13B 1.54B | Sales 2025 * | 203B 1.29B 1.77B | Capitalization | 279B 1.78B 2.43B |
---|---|---|---|---|---|
Net income 2024 | 13.7B 87.52M 119M | Net income 2025 * | 21.7B 139M 189M | EV / Sales 2024 | 1.49 x |
Net Debt 2024 * | 34.69B 222M 303M | Net Debt 2025 * | 36.11B 231M 315M | EV / Sales 2025 * | 1.55 x |
P/E ratio 2024 |
19.3
x | P/E ratio 2025 * |
12.7
x | Employees | 3,393 |
Yield 2024 * |
2.04% | Yield 2025 * |
2.22% | Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
Mitsuo Sawai
CEO | Chief Executive Officer | 67 | 21-03-31 |
President | 66 | 21-03-31 | |
Toru Terashima
BRD | Director/Board Member | 64 | 21-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mitsuo Sawai
CEO | Chief Executive Officer | 67 | 21-03-31 |
Kenzo Sawai
BRD | Director/Board Member | 56 | 21-03-31 |
Masatoshi Ohara
BRD | Director/Board Member | 73 | 21-03-31 |
1st Jan change | Capi. | |
---|---|---|
+31.06% | 682B | |
+30.35% | 586B | |
-3.42% | 364B | |
+18.02% | 327B | |
+4.27% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.12% | 165B |